BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mroweh M, Decaens T, Marche PN, Macek Jilkova Z, Clément F. Modulating the Crosstalk between the Tumor and Its Microenvironment Using RNA Interference: A Treatment Strategy for Hepatocellular Carcinoma. Int J Mol Sci 2020;21:E5250. [PMID: 32722054 DOI: 10.3390/ijms21155250] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Feder S, Bruckmann A, McMullen N, Sinal CJ, Buechler C. Chemerin Isoform-Specific Effects on Hepatocyte Migration and Immune Cell Inflammation. Int J Mol Sci 2020;21:E7205. [PMID: 33003572 DOI: 10.3390/ijms21197205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Saifullah, Sakari M, Suzuki T, Yano S, Tsukahara T. Effective RNA Knockdown Using CRISPR-Cas13a and Molecular Targeting of the EML4-ALK Transcript in H3122 Lung Cancer Cells. Int J Mol Sci 2020;21:E8904. [PMID: 33255340 DOI: 10.3390/ijms21238904] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Ali MAS, Orban R, Rajammal Ramasamy R, Muthusamy S, Subramani S, Sekar K, Rajeena P. P. F, Gomaa IAE, Abulaigh L, Elminaam DSA. A Novel Method for Survival Prediction of Hepatocellular Carcinoma Using Feature-Selection Techniques. Applied Sciences 2022;12:6427. [DOI: 10.3390/app12136427] [Reference Citation Analysis]
4 Wang Y, Guo S, Chen Z, Bai B, Wang S, Gao Y. Re-Clustering and Profiling of Digestive System Tumors According to Microenvironment Components. Front Oncol 2020;10:607742. [PMID: 33643909 DOI: 10.3389/fonc.2020.607742] [Reference Citation Analysis]
5 Mroweh M, Roth G, Decaens T, Marche PN, Lerat H, Macek Jílková Z. Targeting Akt in Hepatocellular Carcinoma and Its Tumor Microenvironment. Int J Mol Sci 2021;22:1794. [PMID: 33670268 DOI: 10.3390/ijms22041794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang Y, Wei H, Fan L, Fang M, He X, Lu B, Pang Z. CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment. Front Cell Dev Biol 2021;9:681372. [PMID: 34409028 DOI: 10.3389/fcell.2021.681372] [Reference Citation Analysis]
7 Zhu Y, Yue M, Guo T, Li F, Li Z, Yang D, Lin M. PEI-PEG-Coated Mesoporous Silica Nanoparticles Enhance the Antitumor Activity of Tanshinone IIA and Serve as a Gene Transfer Vector. Evid Based Complement Alternat Med 2021;2021:6756763. [PMID: 34790248 DOI: 10.1155/2021/6756763] [Reference Citation Analysis]
8 Tian Z, Liang G, Cui K, Liang Y, Wang Q, Lv S, Cheng X, Zhang L. Insight Into the Prospects for RNAi Therapy of Cancer. Front Pharmacol 2021;12:644718. [PMID: 33796026 DOI: 10.3389/fphar.2021.644718] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Jiang Y, Lin L, Lv H, Zhang H, Jiang L, Ma F, Wang Q, Ma X, Yu S. . MBE 2022;19:7178-200. [DOI: 10.3934/mbe.2022339] [Reference Citation Analysis]